Codexis Announces Several Key Presentations from its Gene Therapy Programs at 19th Annual WORLDSymposium™
February 22, 2023 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Feb. 22, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today highlights several key presentations from its gene therapy programs...
Codexis Announces New Employment Inducement Grants
February 15, 2023 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Feb. 15, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the grant of an inducement award to the Company’s recently...
Codexis to Report Fourth Quarter and Fiscal Year 2022 Financial Results on February 23
February 09, 2023 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Feb. 09, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced that it will report its financial results for the fourth...
Codexis Announces Appointment of Sri Ryali as Chief Financial Officer
January 23, 2023 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Jan. 23, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the appointment of Sri Ryali as Chief Financial Officer...
Codexis Announces Appointment of H. Stewart Parker to Board of Directors
December 20, 2022 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Dec. 20, 2022 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the appointment of H. Stewart Parker to its Board of...
Codexis Provides Update on Prioritized Corporate Strategy
November 29, 2022 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Nov. 29, 2022 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced an update on the Company’s ongoing plan to prioritize its...
Codexis to Participate in Piper Sandler 34th Annual Healthcare Conference
November 16, 2022 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Nov. 16, 2022 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company enabling the promise of synthetic biology, today announced that management...
Codexis to Participate in Upcoming Healthcare Conferences
November 08, 2022 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company enabling the promise of synthetic biology, today announced that management...
Codexis Reports Third Quarter 2022 Financial Results
November 03, 2022 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company enabling the promise of synthetic biology, today announced financial...
Codexis Announces Appointment of Margaret Fitzgerald as Chief Legal Officer and General Counsel
November 01, 2022 08:00 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Nov. 01, 2022 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company enabling the promise of synthetic biology, today announced the appointment...